Junlin Yao

1.4k total citations · 1 hit paper
24 papers, 1.1k citations indexed

About

Junlin Yao is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Junlin Yao has authored 24 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 9 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Junlin Yao's work include MicroRNA in disease regulation (5 papers), CAR-T cell therapy research (3 papers) and Quinazolinone synthesis and applications (3 papers). Junlin Yao is often cited by papers focused on MicroRNA in disease regulation (5 papers), CAR-T cell therapy research (3 papers) and Quinazolinone synthesis and applications (3 papers). Junlin Yao collaborates with scholars based in China, United States and Canada. Junlin Yao's co-authors include Hongming Pan, Weidong Han, Ju-Jun Xie, Yubin Zhou, Yicheng Han, Yu Zheng, Yumin Li, Dawei Dong, Liangkun You and Yanyan Yang and has published in prestigious journals such as The Journal of Immunology, International Journal of Cancer and Frontiers in Immunology.

In The Last Decade

Junlin Yao

24 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CD3+CD4-CD8- (Double-Negative) T Cells in Inflammation, Immune Disorders and Cancer

2022 146 citations Yu Zheng, Sheng Jin et al. Frontiers in Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Junlin Yao China	18	541	311	265	259	137	24	1.1k
Ben‐Kuen Chen Taiwan	22	566 1.0×	264 0.8×	171 0.6×	337 1.3×	48 0.4×	43	1.1k
Renpeng Zhou China	19	679 1.3×	174 0.6×	82 0.3×	230 0.9×	64 0.5×	68	1.2k
Lijun Zhao China	15	430 0.8×	88 0.3×	167 0.6×	310 1.2×	92 0.7×	49	755
Dan Yue China	19	406 0.8×	158 0.5×	147 0.6×	127 0.5×	35 0.3×	41	787
Qiongyu Hao United States	15	424 0.8×	153 0.5×	218 0.8×	220 0.8×	53 0.4×	28	789
Miaoqing Zhao China	16	425 0.8×	168 0.5×	171 0.6×	199 0.8×	67 0.5×	75	792
Monish Ram Makena United States	13	562 1.0×	86 0.3×	295 1.1×	196 0.8×	41 0.3×	27	839
Ye Jin Jang South Korea	13	617 1.1×	237 0.8×	205 0.8×	328 1.3×	76 0.6×	15	1.1k
Meena Sharma United States	17	653 1.2×	229 0.7×	127 0.5×	267 1.0×	59 0.4×	25	1.1k
Xuemei Zhang China	24	981 1.8×	100 0.3×	197 0.7×	1000 3.9×	62 0.5×	50	1.4k

Countries citing papers authored by Junlin Yao

Since Specialization

Citations

This map shows the geographic impact of Junlin Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junlin Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junlin Yao more than expected).

Fields of papers citing papers by Junlin Yao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junlin Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junlin Yao. The network helps show where Junlin Yao may publish in the future.

Co-authorship network of co-authors of Junlin Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Junlin Yao. A scholar is included among the top collaborators of Junlin Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junlin Yao. Junlin Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Yiran, et al.. (2024). Concomitant Medications Alter Clinical Outcomes in Patients with Advanced Digestive Tract Cancer Receiving PD-1 Checkpoint Inhibitors Combined with Antiangiogenetic Agents. Journal of Gastrointestinal Cancer. 55(3). 1388–1400. 6 indexed citations

Zhu, Xudong, et al.. (2023). Efficacy and safety of PD‑1 inhibitor plus antiangiogenic treatment in patients with unresectable biliary tract cancer: A multicenter retrospective study. Experimental and Therapeutic Medicine. 26(1). 352–352. 1 indexed citations

Zheng, Yu, Sheng Jin, Yicheng Han, et al.. (2022). CD3+CD4-CD8- (Double-Negative) T Cells in Inflammation, Immune Disorders and Cancer. Frontiers in Immunology. 13. 816005–816005. 146 indexed citations breakdown →

Han, Yicheng, Jiachun Sun, Yunlong Liu, et al.. (2022). TMP195 Exerts Antitumor Effects on Colorectal Cancer by Promoting M1 Macrophages Polarization. International Journal of Biological Sciences. 18(15). 5653–5666. 27 indexed citations

Zheng, Hui, Wenchao Zhu, Hongsen Li, et al.. (2021). A Novel Nutrition-Based Nomogram to Predict Prognosis After Curative Resection of Gastric Cancer. Frontiers in Nutrition. 8. 664620–664620. 4 indexed citations

Yao, Junlin, Sheng Jin, Liangkun You, et al.. (2020). Efficacy and safety of combined immunotherapy and antiangiogenic therapy for advanced non-small cell lung cancer: A two-center retrospective study. International Immunopharmacology. 89(Pt A). 107033–107033. 19 indexed citations

Fang, Linan, Dalam Ly, Sisi Wang, et al.. (2019). Targeting late-stage non-small cell lung cancer with a combination of DNT cellular therapy and PD-1 checkpoint blockade. Journal of Experimental & Clinical Cancer Research. 38(1). 123–123. 47 indexed citations

Yao, Junlin, Dalam Ly, Dzana Dervovic, et al.. (2019). Human double negative T cells target lung cancer via ligand-dependent mechanisms that can be enhanced by IL-15. Journal for ImmunoTherapy of Cancer. 7(1). 17–17. 55 indexed citations

Wu, Yuhui, Junlin Yao, Ju-Jun Xie, et al.. (2018). The role of autophagy in colitis-associated colorectal cancer. Signal Transduction and Targeted Therapy. 3(1). 31–31. 58 indexed citations

10.

Zhao, Jing, Xinbing Sui, Junlin Yao, et al.. (2016). SKF-96365 activates cytoprotective autophagy to delay apoptosis in colorectal cancer cells through inhibition of the calcium/CaMKIIγ/AKT-mediated pathway. Cancer Letters. 372(2). 226–238. 66 indexed citations

11.

Cao, Qian, Junlin Yao, Heyuan Li, et al.. (2016). Cellular Phenotypic Analysis of Macrophage Activation Unveils Kinetic Responses of Agents Targeting Phosphorylation. SLAS DISCOVERY. 22(1). 51–57. 6 indexed citations

12.

Yao, Junlin, Ju-Jun Xie, Binbin Xie, et al.. (2016). Therapeutic effect of hydroxychloroquine on colorectal carcinogenesis in experimental murine colitis. Biochemical Pharmacology. 115. 51–63. 17 indexed citations

13.

Zhang, Yuefei, Hongcui Liu, Junlin Yao, et al.. (2016). Manipulating the air-filled zebrafish swim bladder as a neutrophilic inflammation model for acute lung injury. Cell Death and Disease. 7(11). e2470–e2470. 45 indexed citations

14.

Shou, Jiawei, Liangkun You, Junlin Yao, et al.. (2016). Cyclosporine A sensitizes human non-small cell lung cancer cells to gefitinib through inhibition of STAT3. Cancer Letters. 379(1). 124–133. 50 indexed citations

15.

Xie, Ju-Jun, Hongming Pan, Junlin Yao, Yubin Zhou, & Weidong Han. (2015). SOCE and cancer: Recent progress and new perspectives. International Journal of Cancer. 138(9). 2067–2077. 85 indexed citations

16.

Shou, Jiawei, Jing Jing, Ju-Jun Xie, et al.. (2015). Nuclear factor of activated T cells in cancer development and treatment. Cancer Letters. 361(2). 174–184. 85 indexed citations

17.

Hu, Haiyan, et al.. (2010). Antisense oligonucleotide against miR-21 inhibits migration and induces apoptosis in leukemic K562 cells. Leukemia & lymphoma. 51(4). 694–701. 40 indexed citations

18.

Li, Yumin, Xuejiao Zhu, Dawei Dong, et al.. (2010). Anti‐miR‐21 oligonucleotide sensitizes leukemic K562 cells to arsenic trioxide by inducing apoptosis. Cancer Science. 101(4). 948–954. 60 indexed citations

19.

Zhu, Xuejiao, Yumin Li, Dawei Dong, et al.. (2010). miRNA-21 regulates arsenic-induced anti-leukemia activity in myelogenous cell lines. Medical Oncology. 28(1). 211–218. 40 indexed citations

20.

Li, Yumin, Xuejiao Zhu, Haiyan Hu, et al.. (2010). Anti-miR-21 oligonucleotide enhances chemosensitivity of leukemic HL60 cells to arabinosylcytosine by inducing apoptosis. Hematology. 15(4). 215–221. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact